ALEXANDRIA, Va., April 15 -- United States Patent no. 12,601,748, issued on April 14, was assigned to UNIVERSITE DE GENEVE (Geneva).
"Prospective markers in traumatic brain injury (TBI)" was invented by Jean-Charles Sanchez (Chene-Bourg, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides an in vitro prospective method for determining a recovery outcome in one or more samples of a subject having experienced traumatic brain injury (TBI), comprising the steps of a) determining the level of at least one biomarker selected from the group consisting of H-FABP, IL-10, GFAP, NF-L and S100B; and b) comparing each level obtained under step a) with a corresponding reference value to deter...